Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Polymer-free biolimus-A9-coated stent for primary percutaneous coronary intervention.

Lee DJH, Loh JKK, Jafary FH, Ho HH, Watson T, Stoll HP, Ong PJL.

Herz. 2018 Apr 17. doi: 10.1007/s00059-018-4701-7. [Epub ahead of print]

PMID:
29666900
2.

Treatment with 48-mm everolimus-eluting stents : Procedural safety and 12-month patient outcome.

Tan CK, Tin ZL, Arshad MKM, Loh JKK, Jafary FH, Ho HH, Ong PJL, Watson T.

Herz. 2018 Jan 16. doi: 10.1007/s00059-017-4670-2. [Epub ahead of print]

PMID:
29340719
3.

Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention.

Sim WJ, Ang AS, Tan MC, Xiang WW, Foo D, Loh KK, Jafary FH, Watson TJ, Ong PJL, Ho HH.

PLoS One. 2017 Sep 21;12(9):e0185186. doi: 10.1371/journal.pone.0185186. eCollection 2017.

4.

Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease.

Sinaga DA, Ho HH, Watson TJ, Sim A, Nyein TT, Jafary FH, Loh JK, Ooi YW, Tan JK, Ong PJ.

J Interv Cardiol. 2016 Oct;29(5):454-460. doi: 10.1111/joic.12333. Epub 2016 Aug 30.

PMID:
27578540
5.

"First-in-man" report of successful use of drug-coated balloon angioplasty in primary percutaneous coronary intervention to treat a patient with 2 discrete ST-elevation myocardial infarction.

Ho HH, Ong PJ, Jafary FH.

Int J Cardiol. 2016 Jul 1;214:19-20. doi: 10.1016/j.ijcard.2016.03.097. Epub 2016 Mar 28. No abstract available.

PMID:
27055161
6.

Drug coated balloon angioplasty in elderly patients with small vessel coronary disease.

Sinaga DA, Ho HH, Zeymer U, Waliszewski M, Jafary FH, Ooi YW, Loh JK, Tan JK, Ong PJ.

Ther Adv Cardiovasc Dis. 2015 Dec;9(6):389-96. doi: 10.1177/1753944715598714. Epub 2015 Aug 11.

PMID:
26265774
7.

Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention.

Ho HH, Tan J, Ooi YW, Loh KK, Aung TH, Yin NT, Sinaga DA, Jafary FH, Ong PJ.

World J Cardiol. 2015 Jun 26;7(6):311-4. doi: 10.4330/wjc.v7.i6.311. Review.

8.

Editorial: drug-coated balloon for coronary indications: too little, too late.

Ong PJ, Jafary FH, Ho HH.

J Interv Cardiol. 2015 Apr;28(2):218-9. doi: 10.1111/joic.12183. No abstract available.

PMID:
25884901
9.

Predictors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock in the contemporary era of primary percutaneous coronary intervention.

Ho HH, Ong HA, Arasaratnam P, Ooi YW, Tan J, Loh KK, Foo D, Jafary FH, Ong PJL.

Int J Cardiol Heart Vessel. 2014 Apr 24;3:88-89. doi: 10.1016/j.ijchv.2014.04.001. eCollection 2014 Jun. No abstract available.

10.

Clinical Efficacy and Safety of SeQuent Please Paclitaxel-Eluting Balloon in a Real-World Single-Center Registry of South-East Asian Patients.

Ho HH, Ooi YW, Loh KK, Tan J, Aung TH, Jafary FH, Ong PJL.

Int J Cardiol Heart Vessel. 2013 Nov 27;1:37-41. doi: 10.1016/j.ijchv.2013.11.008. eCollection 2013 Dec.

11.

Acute coronary syndrome: is it the primary event or a secondary phenomenon?

Wong CP, Ho HH, Joseph Francis P, Jafary FH, Foo D, Yong QW.

Ann Acad Med Singapore. 2013 Sep;42(9):478-9. No abstract available.

12.

"First-in-man" use of bioresorbable vascular scaffold in saphenous vein graft.

Ong PJ, Jafary FH, Ho HH.

EuroIntervention. 2013 May 20;9(1):165. doi: 10.4244/EIJV9I1A24. No abstract available.

13.

Deliverability of integrity coronary stents in severely tortuous coronary arteries: a preliminary experience.

Ho HH, Jafary FH, Loh KK, Tan JK, Ooi YW, Ong PJ.

J Invasive Cardiol. 2012 Dec;24(12):650-4.

14.

Rheolytic thrombectomy in patients with massive pulmonary embolism: a report of two cases and review of literature.

Wong CP, Ho HH, Jafary FH, Ong PJ.

Acute Card Care. 2012 Sep;14(3):91-3. doi: 10.3109/17482941.2012.682068. Epub 2012 May 1. Review.

PMID:
22548712
15.

Clinical outcomes of intracoronary eptifibatide bolus only versus intracoronary bolus and intravenous infusion of eptifibatide in primary percutaneous coronary intervention.

Soon D, Ho HH, Loh KK, Ooi YW, Foo D, Jafary FH, Ong PJ.

Acute Card Care. 2012 Mar;14(1):42-4. doi: 10.3109/17482941.2012.655288. Epub 2012 Jan 24.

PMID:
22273457
16.

Radial artery spasm during transradial cardiac catheterization and percutaneous coronary intervention: incidence, predisposing factors, prevention, and management.

Ho HH, Jafary FH, Ong PJ.

Cardiovasc Revasc Med. 2012 May-Jun;13(3):193-5. doi: 10.1016/j.carrev.2011.11.003. Epub 2012 Jan 5. Review.

PMID:
22226169
17.

Good visibility of TITAN-2 coronary stents demonstrable on cardiac computer tomographic angiography: a report of 2 cases.

Ong PJ, Ho HH, Jafary FH, Loh KK, Ooi YW, Wong CP, Foo D.

Acute Card Care. 2011 Sep;13(3):202-4. doi: 10.3109/17482941.2011.606470. Erratum in: Acute Card Care. 2012 Sep;14(3):110. Jau, Ong Paul [corrected to Ong, Paul Jau]; Hwa, Ho Hee [corrected to Ho, Hee Hwa]; Haider, Jafary Fahim [corrected to Jafary, Fahim Haider]; Kong, Loh Kwok [corrected to Lob, Kwok Kong]; Wei, Ooi Yau [corrected to Ooi, Yau Wei]; Pong, Wong Chun [corrected.

PMID:
21877881
19.

Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial.

Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A, Badruddin SH, Chaturvedi N; Hypertension Research Group.

Ann Intern Med. 2009 Nov 3;151(9):593-601. doi: 10.7326/0003-4819-151-9-200911030-00004.

PMID:
19884620
20.

Results of a cross-sectional survey about lipid-management practices among cardiologists in Pakistan: assessment of adherence to published treatment guidelines.

Gowani SA, Shoukat S, Taqui AM, Bhulani N, Khalid S, Sheikh A, Halim MS, Samreen S, Jafary FH.

Clin Ther. 2009 Jul;31(7):1604-14. doi: 10.1016/j.clinthera.2009.07.020.

PMID:
19695410

Supplemental Content

Loading ...
Support Center